Sign in
CompletedNo phase

Post-market Evaluation of Clinical Outcomes in China for the TECNIS Model ZMT

Key facts

Who runs it
Johnson & Johnson Surgical Vision, Inc.
Where
China7 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
102 people enrolled
Started
11 Aug 2021
Ended
10 Jan 2024
Type of study
Interventional
Treatments tested
  • Study Lens: TECNIS Multifocal Toric 1-piece lens, Model ZMT
Record updated
23 May 2025

Who can take part

Age
22 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Male or female at least 22 years of age
  • Have a cataract in one or both eyes, with planned phacoemulsification with intraocular lens implantation
  • Regular corneal astigmatism that is planned for correction with an intraocular lens in the study eye(s)
  • Availability, willingness and sufficient cognitive awareness to understand the purpose of the examination procedures and comply with postoperative visits that are required by the study protocol
  • Voluntary participation indicated by the study informed consent form (ICF) signed by the patient or legal guardian

Who cannot take part

  • Concurrent participation or participation in any other clinical study within 30 days prior to the preoperative visit
  • Ocular disease (other than cataract) that may significantly affect postoperative vision, such as visually significant keratopathy, macular lesions, diabetic retinopathy, chronic or severe uveitis, etc
  • Severe or unstable systemic disease that may affect the heart, liver, kidney, lung, endocrine (including thyroid insufficiency), blood, or psychoneurological dysfunction
  • Any other systemic or ocular disease that, in the opinion of the investigator, may affect the patient's eligibility for the study; -
  • Planned monovision correction (one eye designated for near correction)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is a prospective, multicenter, single-arm, open-label clinical study of the commercially available TECNIS Multifocal Toric 1-Piece IOL. The study will enroll up to 120 subjects from up to 8 sites in China. The subjects will be followed for 12-months postoperatively.

The group in the trial

  • Study LensTreatment being tested

    TECNIS Multifocal Toric 1-piece lens, Model ZMT

    Treatment: Study Lens: TECNIS Multifocal Toric 1-piece lens, Model ZMT

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Post-market Evaluation of Clinical Outcomes in China for the TECNIS® Multifocal Toric 1-Piece Intraocular Lens Model Series ZMT
Record updated
23 May 2025